Lecture 11: Pathophysiology & Management of Thrombosis

Gerald A Soff MD

Presentation Date:

November 20, 2025

About This Lecture

Venous Thromboembolism (VTE) is common, and the 3rd leading cause of thrombosis-related death. Some estimate as many as 900,000 people could be affected (1 to 2 per 1,000) each year in the United States.
60,000-100,000 Americans die of VTE.
Understanding the causes and management of VTE is a core part of Classical Hematology as well as primary care.

Slide Deck

Continuing Education Credit

Gerald A Soff MD

Chief, Classical Hematology Service
Sylvester Comprehensive Cancer Center,
University of Miami Health System
gas199@Miami.edu

Speaker Disclosures

Disclosures for Gerald A Soff MD.
Research Support (Past 2 years):
Amgen, Sobi/Dova Pharmaceuticals
Anthos Therapeutics

Data Safety Monitoring Committee
Alpine Immune Sciences

Advisory Boards (Past 2 years)
Sanofi , Novartis

Learning Objectives

At conclusion of the presentation, the learner should be familiar with the (1) Mechanisms of VTE, (2) the treatment of VTE,